Propeller Health and GlaxoSmithKline (GSK) will extend their collaboration in which patients with chronic obstructive pulmonary disease (COPD) and asthma use Propeller’s clip-on sensor and software platform with GSK’s Ellipta Inhaler to help them manage their illnesses.

The new extended partnership, first announced in 2015, will allow Propeller and GSK to commercialize Propeller’s digital respiratory health management system in conjunction with the Ellipta inhaler.

GSK has been developing medicines to manage COPD and asthma for the past 45 years. Propeller develops sensors, mobile apps and services that help improve the quality of life for people with chronic respiratory diseases.

The sensor registers use of the inhaler. Propeller’s software platform analyzes that data and presents it to patients and clinicians through data-driven digital interfaces.

“We are excited to be working closely with GSK to make the sensor for the Ellipta inhaler available in our commercial programs, and for the first time, as part of commercial pilots with GSK outside the U.S.,” David Van Sickle, CEO and co-founder of Propeller, said in a press release. “Companion digital experiences simplify and personalize the management of chronic respiratory disease, and help ensure individuals and their physicians realize the benefits of inhaled medicines.”

Propeller’s software is widely used throughout the United States, and is compatible with most inhaler devices used by COPD and asthma patients including controller and reliever metered dose inhalers, as well as dry powder inhalers and soft mist inhalers.

“Digital innovations, like sensor technologies, will help us ensure patients receive the best possible package of care management and treatment for their respiratory condition,” said Eric Dube, GSK’s senior vice-president and head of its global respiratory franchise. “We are excited to expand our collaboration with Propeller as a further step in our journey towards achieving connected health systems for people with asthma and COPD.”

COPD News Today

Disclaimer:

COPD News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Pin It on Pinterest

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more